Nektar Therapeutics (ITH.F) Q4 2024 Earnings

Nov 7Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.23
-0.21
-0.19
-0.17

Details

Expected EPS
-0.18424822553
Actual EPS
-0.1666458
Surprise EPS
0.02
Surprise Percent
+9.55%

Description

⁨Nektar Therapeutics⁩ (⁦ITH.F⁩) has reported earnings of ⁦-0.1666458⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts